Ronapreve, Monupiravir, Sotrovimab, only for some - and only when infected?
This does not sound like protecting the immunocompromised - more like shutting the stable door for some and leaving it wide open for others.
(These new treatments are not approved in the UK forCML, CMML, MPNs (PV,
ET, myelofibrosis), MDS, LGLL, and other chronic blood cancers that do
not affect B cells (B lymphocytes) and ONLY on confirmation of a positive PCR test)
Please MPN Voice confirm that you are petitioning for these treatments as a preventative for the entire Blood Cancer cohort, and help us re-enter life and stop shielding....